Cargando…
Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
Gonadotropin therapy is commonly used to induce virilization and spermatogenesis in male isolated hypogonadotropic hypogonadism (IHH) patients. In clinical practice, 5.6%–15.0% of male IHH patients show poor responses to gonadotropin treatment; therefore, testosterone (T) supplementation can serve a...
Autores principales: | Chen, Yin-Wei, Niu, Yong-Hua, Xu, Hao, Wang, Dao-Qi, Jiang, Hong-Yang, Pokhrel, Gaurab, Wang, Tao, Wang, Shao-Gang, Liu, Ji-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628746/ https://www.ncbi.nlm.nih.gov/pubmed/30604694 http://dx.doi.org/10.4103/aja.aja_107_18 |
Ejemplares similares
-
Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism
por: Lin, Jianli, et al.
Publicado: (2019) -
Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021) -
Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2017) -
Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021) -
Treatment situation of male hypogonadotropic hypogonadism in pediatrics and
proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)